Iminopyrimidinones: A novel pharmacophore for the development of orally active renin inhibitors

被引：6

作者：

McKittrick, Brian A. ^{[1
]}

Caldwell, John P. ^{[1
]}

Bara, Thomas ^{[1
]}

Boykow, George ^{[3
]}

Chintala, Madhu ^{[3
]}

Clader, John ^{[1
]}

Czarniecki, Michael ^{[1
]}

Courneya, Brandy ^{[6
]}

Duffy, Ruth ^{[3
]}

Fleming, Linda

Giessert, Rachel ^{[6
]}

Greenlee, William J. ^{[1
]}

Heap, Charles

Hong, Liwu ^{[1
]}

Huang, Ying ^{[1
]}

Iserloh, Ulrich ^{[1
]}

Josien, Hubert ^{[1
]}

Khan, Tanweer ^{[1
]}

Korfmacher, Walter ^{[4
]}

Liang, Xian ^{[1
]}

Mazzola, Robert ^{[1
]}

Mitra, Soumya ^{[6
]}

Moore, Kristina ^{[3
]}

Orth, Peter ^{[2
]}

Rajagopalan, Murali ^{[1
]}

Roy, Sudipta ^{[6
]}

Sakwa, Samuel ^{[6
]}

Strickland, Corey ^{[2
]}

Vaccaro, Henry ^{[1
]}

Voigt, Johannes ^{[2
]}

Wang, Hongwu ^{[2
]}

Wong, Jesse ^{[1
]}

Zhang, Rumin ^{[5
]}

Zych, Andrew ^{[6
]}

机构：

[1] Merck Res Labs, Discovery Chem, Kenilworth, NJ 07033 USA

[2] Merck Res Labs, Struct Chem, Kenilworth, NJ 07033 USA

[3] Merck Res Labs, Cardiovasc Pharmacol, Kenilworth, NJ 07033 USA

[4] Merck Res Labs, Pharmacokinet Pharmacodynam & Metab, Kenilworth, NJ 07033 USA

[5] Merck Res Labs, Biochem & Biophys, Kenilworth, NJ 07033 USA

[6] Albany Mol Res Inc, Dept Med Chem, Albany, NY 12203 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015年 / 25卷 / 07期

关键词：

Renin inhibitors; BACE1; Hypertension; Structure-based drug design; Enzyme inhibitors; STRUCTURE-BASED DESIGN; BACE1; INHIBITORS; TRANSGENIC RATS; DRUG DISCOVERY; HYPERTENSION; ALISKIREN; POTENT; MANAGEMENT; VTP-27999; PART;

D O I：

10.1016/j.bmcl.2015.02.003

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The development of renin inhibitors with favorable oral pharmacokinetic profiles has been a longstanding challenge for the pharmaceutical industry. As part of our work to identify inhibitors of BACE1, we have previously developed iminopyrimidinones as a novel pharmacophore for aspartyl protease inhibition. In this letter we describe how we modified substitution around this pharmacophore to develop a potent, selective and orally active renin inhibitor. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：1592 / 1596

页数：5

共 50 条

[1] A NOVEL NONPEPTIDIC, ORALLY ACTIVE RENIN INHIBITOR
MORISHIMA, H
KOIKE, Y
NAKANO, M
ATSUUMI, S
TANAKA, S
FUNABASHI, H
HASHIMOTO, J
SAWASAKI, Y
MINO, N
NAKANO, M
MATSUSHIMA, K
NAKAMICHI, K
YANO, M
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (03) : 999 - 1005
[2] Design and synthesis of novel potent, non-peptide and orally active renin inhibitors
Maibaum, J
Rasetti, V
Rueger, H
Cohen, NC
Goschke, R
Mah, R
Rahuel, J
Grutter, M
Cumin, F
Wood, JM
MEDICINAL CHEMISTRY: TODAY AND TOMORROW, 1997, : 155 - 162
[3] Orally active non-peptide inhibitors of human renin
Barrett, D
Langston, S
DRUG DISCOVERY TODAY, 2001, 6 (01) : 52 - 52
[4] New class of potent, nonpeptidic, orally active renin inhibitors
Remen, Lubos
Bezencon, Olivier
Boss, Christoph
Bur, Daniel
Corminboeuf, Olivier
Grisostomi, Corinna
Richard-Bildstein, Sylvia
Sifferlen, Thierry
Weller, Thomas
Binkert, Christoph
Fischli, Walter
Hess, Patrick
Prade, Lars
Steiner, Beat
Strickner, Panja
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
[5] DESIGN AND SYNTHESIS OF NOVEL POTENT, NON-PEPTIDE AND ORALLY ACTIVE RENIN INHIBITORS.
Grutter, M.
Maibaum, J.
Rasetti, V.
Rueger, H.
Goschke, R.
Mah, R.
Cohen, N. C.
Rahuel, J.
Cumin, F.
Wood, J.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C583 - C583
[6] Structure based drug design and discovery of iminopyrimidinones as potent renin inhibitors
Khan, Tanweer A.
Mckittrick, Brian A.
Orth, Peter
Wang, Hongwu
Strickland, Corey
Voigt, Johannes
Hubert, Josien
Caldwel, John
Vaccaro, Henry A.
Rajagopalan, Murali
Bara, Thomas
Hong, Liwu
Mazzola, Robert D.
Huang, Ying
Iserloh, Ulrich
Wong, Jesse
Liang, Mark
Heap, Charles
Zych, Andrew
Courneya, Brandy
Fleming, Linda
Giessert, Rachel
Mitra, Shomo
Roy, Sudipta
Sakwa, Samuel
Duffy, Ruth
Chintala, Madhu
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[7] RENIN INHIBITORS - A PARADIGM FOR PEPTIDE-BASED ORALLY ACTIVE COMPOUNDS
KLEINERT, HD
BAKER, WR
ROSENBERG, SH
STEIN, HH
JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 210 - 210
[8] Structure-based drug design:: the discovery of novel nonpeptide orally active inhibitors of human renin
Rahuel, J
Rasetti, V
Maibaum, J
Rüeger, H
Göschke, R
Cohen, NC
Stutz, S
Cumin, F
Fuhrer, W
Wood, JM
Grütter, MG
CHEMISTRY & BIOLOGY, 2000, 7 (07): : 493 - 504
[9] HIGHLY POTENT, ORALLY ACTIVE DIESTER MACROCYCLIC HUMAN RENIN INHIBITORS
WEBER, AE
STEINER, MG
TATA, JR
DOYLE, JJ
SCHORN, TW
SIEGL, PKS
GREENLEE, WJ
PATCHETT, AA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 123 - MEDI
[10] HIGHLY POTENT, ORALLY ACTIVE DIESTER MACROCYCLIC HUMAN RENIN INHIBITORS
WEBER, AE
STEINER, MG
KRIETER, PA
COLLETTI, AE
TATA, JR
HALGREN, TA
BALL, RG
DOYLE, JJ
SCHORN, TW
STEARNS, RA
MILLER, RR
SIEGL, PKS
GREENLEE, WJ
PATCHETT, AA
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (21) : 3755 - 3773

← 1 2 3 4 5 →